In conclusion, EVO can upregulate tumor-suppressor miRNAs and downregulate oncogenic lncRNA NEAT1, providing molecular mechanisms linking EVO to non-coding RNAs that can contribute, in part, to its anti-cancer activities. This evidence concerns the gene NEAT1 and cancer.